← Leaderboards
Sankar Dass Navaneethan
Michael E Debakey Va Medical Center
$3,448,418
Attributed
$3,448,418
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $709.9K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,448,418 · 2
VA$0 · 1
By mechanism
R01$2,977,340 · 1
K24$471,078 · 1
I01$0 · 1
Top collaborators
- Salim S Virani5 shared
Most similar at Michael E Debakey Va Medical Center
Same institution · by research overlap
- Salim S Virani$61,295
- Lavannya M. Pandit$762,380
Others in their field
Top investigators on “Disease Progression”
- Lawrence Corey · Fred Hutchinson Cancer Center$405,086,239
- Constance Ann Benson · University Of California, San Diego$244,117,339
- Jeffrey P Krischer · University Of South Florida$225,151,653
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$150,116,206
- Peter B. Gilbert · Fred Hutchinson Cancer Center$146,027,526
Research focus
Disease ProgressionNon-DiabeticHypertensionDiabeticCardiovascular SystemCardiovascular DiseasesChronic Kidney FailureMorbidity - Disease RateEventEnd Stage Renal FailureKidney DiseasesDiabetes MellitusMortalityHigh PrevalenceAlbuminuriaGuidelinesMortality RiskPharmaceutical PreparationsCessation Of LifeFollow-UpLearningAngiotensin-Converting Enzyme InhibitorsCreatinineReporting
Grant awards (15)
MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE$117,491
K24 · FY2025 · HL · contact PI
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2025 · VA · contact PI
MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE$117,640
K24 · FY2024 · HL · contact PI
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2024 · VA · contact PI
MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE$117,771
K24 · FY2023 · HL · contact PI
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2023 · VA · contact PI
MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE$118,176
K24 · FY2022 · HL · contact PI
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2022 · VA
Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease$0
I01 · FY2020 · VA
Visceral Adiposity and Physical Fitness in CKD$522,553
R01 · FY2018 · DK · contact PI
Visceral Adiposity and Physical Fitness in CKD$533,769
R01 · FY2017 · DK · contact PI
Visceral Adiposity and Physical Fitness in CKD$607,971
R01 · FY2016 · DK · contact PI
Visceral Adiposity and Physical Fitness in CKD$603,183
R01 · FY2015 · DK · contact PI
Visceral Adiposity and Physical Fitness in CKD$1
R01 · FY2015 · DK · contact PI
Visceral Adiposity and Physical Fitness in CKD$709,863
R01 · FY2014 · DK · contact PI